Profile of D-Dimer Levels in Patients Confirmed Positive for COVID-19 at the Indonesian Christian University Hospital
Danny Ernest Jonas Luhulima, Agriva Taufan Vicani Damanik, Tiroy Sari B. Simanjuntak
International Journal of TROPICAL DISEASE & Health · pp. 201–213 · Published 1 Aug 2024
10.9734/ijtdh/2024/v45i71574Abstract
Aims: the research aimed to determine the profile of d-dimer levels in patients confirmed positive for COVID-19 at UKI Hospital from December 2020 to September 2021 Study Design: This type of research is descriptive research with a retrospective cross-sectional research design, namely using secondary data in the form of UKI RS medical records. Place and Duration of Study: The research was carried out in the medical records section of RS UKI from May to October 2021. Methodology: The research samples were all medical records of patients suffering from COVID-19 with an age range of 18 to 45 years and their D-Dimer levels were checked during treatment at UKI Hospital for the period December 2020 to September 2021, totaling 148 samples. This data will be processed and analyzed using the Chi-Square Test. Results: From the results of the study, it was found that there were 129 patients (87.2%) with COVID-19 who had normal D-Dimer levels and 19 patients (12.8%) who had elevated D-Dimer levels. Obtained a p-value of 0.677, which means that there is no statistically significant relationship between clinical symptoms and increased levels of D-Dimer in COVID-19 patients. However, there is a statistically significant relationship between the administration of anticoagulants and an increase in D-Dimer levels in COVID-19 patients with a p-value of 0.015. Conclusion: It can be concluded that there is a significant relationship between anticoagulants and D-Dimer levels in COVID-19 patients with moderate and severe symptoms (in this case administration of anticoagulants can inhibit the increase in D-Dimer), but researchers did not find a significant relationship with mild symptoms.
References (13)
- 1 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor [DOI]
- 2 Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 [DOI]
- 3 Origin and evolution of pathogenic coronaviruses [DOI]
- 4 Coronavirus Disease 2019: Tinjauan Literatur Terkini [DOI]
- 5 Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review [DOI]
- 6 COVID-19 diagnosis —A review of current methods [DOI]
- 7 Detection technologies and recent developments in the diagnosis of COVID-19 infection [DOI]
- 8 Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020 [DOI]
- 9 CORONAVIRUS DISEASE 2019 (COVID-19): A LITERATURE REVIEW [DOI]
- 10 Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019: Serologic Testing [DOI]
- 11 Koagulopati pada Coronavirus Disease-2019 (COVID-19): Tinjauan pustaka [DOI]
- 12 Integration of COVID 19 Vaccination into Routine Immunization Services in Belize [DOI]
- 13 Local Immunity Concept in the Context of the Novel Corona Viral Infection: A Consideration
Cited by 0
No indexed citations yet.
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
32
Page views
0
PDF downloads
4
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.